PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Cash Flow Growth
-22.61%
TTM · Period ending:
PHAS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.61%period ending
Latest reported-22.61%period ending
PHAS TTM Cash from Operations YoY % (-162.52% → -22.61%)
Year-over-year change
High-resolution chart · PNG
PHAS operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -22.6136% | |
| -29.7216% | |
| 20.9167% | |
| 36.5526% | |
| 9.4405% | |
| 15.2862% | |
| -51.4295% | |
| -80.0106% | |
| -82.7726% | |
| -136.2419% | |
| -132.182% | |
| -168.5576% | |
| -162.5213% |